Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral versus intravenous dexamethasone bioequivalence in community-acquired pneumonia
NL-OMON36192Phase 4Active, not recruiting
- Sponsor
- St. Antonius Ziekenhuis
- Start
- Sep 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexamethasone and dexamethasone sodium phosphate in community-acquired pneumonia (CAP), pneumonia and pulmonary infection (2 arms), sponsored by St. Antonius Ziekenhuis. Primary endpoint: AUC0-24. Started Sep 2011; status: active, not recruiting.
02
Drugs
dexamethasonedexamethasone sodium phosphate
03
Conditions
community-acquired pneumonia (CAP)pneumoniapulmonary infection
Beyond the preview
Go deeper on NL-OMON36192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36192.